No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs13117257 |
chr4:7521802-7521803 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs75891318 |
chr4:7521856-7521857 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs187862806 |
chr4:7521866-7521867 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs11735062 |
chr4:7521878-7521879 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs568856829 |
chr4:7521904-7521905 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs190035746 |
chr4:7521907-7521908 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs574974159 |
chr4:7521914-7521915 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs558744944 |
chr4:7521946-7521947 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs182748812 |
chr4:7521947-7521948 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs533733209 |
chr4:7521990-7521991 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs555185983 |
chr4:7521999-7522000 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs567408589 |
chr4:7522024-7522025 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs577068055 |
chr4:7522033-7522034 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs187482936 |
chr4:7522041-7522042 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs192953599 |
chr4:7522078-7522079 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs184560336 |
chr4:7522125-7522126 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs554452201 |
chr4:7522129-7522130 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs572823904 |
chr4:7522132-7522133 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs376486740 |
chr4:7522152-7522153 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs4689772 |
chr4:7522187-7522188 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs573750362 |
chr4:7522234-7522235 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs4689773 |
chr4:7522239-7522240 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
23 |
rs552577608 |
chr4:7522252-7522253 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs562302170 |
chr4:7522283-7522284 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs6819749 |
chr4:7522335-7522336 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs551135034 |
chr4:7522342-7522343 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs560383737 |
chr4:7522344-7522345 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs111421398 |
chr4:7522375-7522376 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs561041963 |
chr4:7522378-7522379 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs78033216 |
chr4:7522384-7522385 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs537915674 |
chr4:7522449-7522450 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs550258435 |
chr4:7522462-7522463 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs571505461 |
chr4:7522542-7522543 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs73082847 |
chr4:7522545-7522546 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs565867383 |
chr4:7522578-7522579 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs4689774 |
chr4:7522628-7522629 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs572754151 |
chr4:7522633-7522634 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs536967015 |
chr4:7522672-7522673 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs188694412 |
chr4:7522678-7522679 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs576717071 |
chr4:7522702-7522703 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs140574754 |
chr4:7522742-7522743 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs73082848 |
chr4:7522755-7522756 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs149892199 |
chr4:7522772-7522773 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs569617958 |
chr4:7522800-7522801 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs577702037 |
chr4:7522813-7522814 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs544975434 |
chr4:7522874-7522875 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs74668548 |
chr4:7522918-7522919 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs527556857 |
chr4:7522919-7522920 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs571764524 |
chr4:7522920-7522921 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs548882648 |
chr4:7522944-7522945 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|